BUDESONIDE (1mg orodipersible tablet) (Jorveza®)

Clinical Indication

For treatment of eosinophilic esophagitis in adults and children

Comments

NICE TA708

Date of classification

March 2020

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.